Featured Research

from universities, journals, and other organizations

Silence Of The Genes: Researchers Provide Unique View Of Inherited Disorders And Cancer

Date:
June 1, 2004
Source:
University Of Southern California
Summary:
Dispelling the belief that the only way to treat such conditions is by fixing or replacing damaged genes, researchers from the USC/Norris Comprehensive Cancer Center are instead focusing on the field of epigenetics--the study of changes in gene silencing that occur without changes in the genes themselves.

Los Angeles, CA, May 27, 2004 -- Researchers from the USC/Norris Comprehensive Cancer Center are heralding an entirely new approach to the treatment of aging, inherited diseases and cancer in a review paper published in today's issue of the journal Nature. Dispelling the belief that the only way to treat such conditions is by fixing or replacing damaged genes, they are instead focusing on the field of epigenetics--the study of changes in gene silencing that occur without changes in the genes themselves.

Related Articles


Many genes in our bodies are permanently turned off as part of normal development. But sometimes that process goes awry, turning off genes that should otherwise remain active. The new field of epigenetic therapy, put forth by the USC researchers in their Nature review paper, aims to switch these genes back on.

In their article, Peter Jones, Ph.D., director of USC/Norris and Distinguished Professor of Biochemistry and Molecular Biology and Urology at the Keck School of Medicine of the University of Southern California, and his colleagues lay out their new perspective on the treatment of genetic disorders by discussing the potential ways to interfere with epigenetic gene silencing, and the ways in which that potential is already being exploited.

"The fact that many human diseases, including cancer, have an epigenetic etiology has encouraged the development of a new therapeutic option that might be termed 'epigenetic therapy,'" Jones and his colleagues write. They add that a number of chemical compounds have been found that have an affect on some form of epigenetic gene change, and note that "several of these agents are currently being tested in clinical trials," including trials being conducted at USC/Norris.

This Nature review comes just days after the U.S. Food and Drug Administration (FDA) approved the epigenetic inhibitor azacitidine (Vidaza(tm), Pharmion Corporation) for the treatment of a pre-leukemic bone-marrow disorder known as myelodysplastic syndrome, or MDS. MDS, which is characterized by the production of abnormal, immature blood cells, affects between 10,000 and 30,000 people each year, is most prevalent in people over age 60, and can be fatal. Until now, there was no approved treatment for MDS.

Azacitidine was first synthesized in the 1960s in Czechoslovakia; it received its first exposure in the United States in the Childrens Hospital Los Angeles laboratory of then-fellow Peter Jones. Although the drug had initially been envisioned as a chemotherapy agent, Jones showed that it had great utility in the laboratory because it could turn on genes that had been previously locked down by methylation--a type of epigenetic change in which a methyl group becomes physically attached to the region of a gene that regulates its production of protein, shutting it down.

But Jones, who is one of the world's pre-eminent epigenetics experts, says that azacitidine's approval is bigger than its role in MDS.

"This is the first approved drug in a new kind of therapy-epigenetic therapy," Jones notes. "That gives it tremendous potential importance not just in this disease, but in a host of others as well."

Indeed, cancer and its relatives are far from the only conditions that may be affected by epigenetic gene silencing, Jones notes. A number of other diseases--most notably several that can lead to intellectual disabilities--appear to have epigenetic roots. Among them are Fragile X syndrome, Angelman syndrome, Prader-Willi syndrome and Rett syndrome. Jones also sees the application of epigenetics to combat disorders caused by aging, providing the opportunity to turn on the genes shut down by the aging process.

And the search for the right drugs to undo the epigenetic damage is equally wide-ranging. Jones is involved in research into the utility of a compound called azadeoxycytidine--a more specific version of azacitidine that only affects DNA and thus potentially carries fewer side effects. Many of the major pharmaceutical companies have at least one methylation inhibitor trial ongoing, Jones adds, and there are dozens of additional compounds being screened for their potential utility.

"It is apparent that we are just at the beginning of understanding the substantial contributions of epigenetics to human disease, and there are probably many surprises ahead," Jones and colleagues note in their review. "Elucidating the whole bandwidth of epigenetic mechanisms is an exciting challenge and will eventually lead to a clearer understanding of the development of human disease and direct therapeutic concepts into new directions."

###

Gerda Egger, Gangning Liang, Ana Aparicio, Peter Jones, "Epigenetics in human disease and prospects for epigenetic therapy." Nature, 429:457-463, 27 May 2004.


Story Source:

The above story is based on materials provided by University Of Southern California. Note: Materials may be edited for content and length.


Cite This Page:

University Of Southern California. "Silence Of The Genes: Researchers Provide Unique View Of Inherited Disorders And Cancer." ScienceDaily. ScienceDaily, 1 June 2004. <www.sciencedaily.com/releases/2004/05/040531214232.htm>.
University Of Southern California. (2004, June 1). Silence Of The Genes: Researchers Provide Unique View Of Inherited Disorders And Cancer. ScienceDaily. Retrieved December 19, 2014 from www.sciencedaily.com/releases/2004/05/040531214232.htm
University Of Southern California. "Silence Of The Genes: Researchers Provide Unique View Of Inherited Disorders And Cancer." ScienceDaily. www.sciencedaily.com/releases/2004/05/040531214232.htm (accessed December 19, 2014).

Share This


More From ScienceDaily



More Health & Medicine News

Friday, December 19, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

The Best Tips to Curb Holiday Carbs

The Best Tips to Curb Holiday Carbs

Buzz60 (Dec. 19, 2014) It's hard to resist those delicious but fattening carbs we all crave during the winter months, but there are some ways to stay satisfied without consuming the extra calories. Vanessa Freeman (@VanessaFreeTV) has the details. Video provided by Buzz60
Powered by NewsLook.com
Sierra Leone Bikers Spread the Message to Fight Ebola

Sierra Leone Bikers Spread the Message to Fight Ebola

AFP (Dec. 19, 2014) More than 100 motorcyclists hit the road to spread awareness messages about Ebola. Nearly 7,000 people have now died from the virus, almost all of them in west Africa, according to the World Health Organization. Video provided by AFP
Powered by NewsLook.com
Researchers Test Colombian Village With High Alzheimer's Rates

Researchers Test Colombian Village With High Alzheimer's Rates

AFP (Dec. 19, 2014) In Yarumal, a village in N. Colombia, Alzheimer's has ravaged a disproportionately large number of families. A genetic "curse" that may pave the way for research on how to treat the disease that claims a new victim every four seconds. Duration: 02:42 Video provided by AFP
Powered by NewsLook.com
Kids Die While Under Protective Services

Kids Die While Under Protective Services

AP (Dec. 18, 2014) As part of a six-month investigation of child maltreatment deaths, the AP found that hundreds of deaths from horrific abuse and neglect could have been prevented. AP's Haven Daley reports. (Dec. 18) Video provided by AP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins